loxiglumide has been researched along with erythromycin in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Jansen, JB; Jebbink, MC; Lamers, CB; Masclee, AA; Rovati, LC; Schipper, J; van der Kleij, FG | 1 |
| Pelosini, I; Scarpignato, C | 1 |
1 review(s) available for loxiglumide and erythromycin
| Article | Year |
|---|---|
Management of irritable bowel syndrome: novel approaches to the pharmacology of gut motility.
Topics: Animals; Cisapride; Colonic Diseases, Functional; Erythromycin; Gastrointestinal Agents; Gastrointestinal Motility; Hormone Antagonists; Humans; Octreotide; Parasympatholytics; Proglumide; Receptors, Adrenergic, beta; Receptors, Cholecystokinin; Receptors, Muscarinic; Receptors, Neurokinin-2; Receptors, Serotonin; Serotonin Antagonists | 1999 |
3 other study(ies) available for loxiglumide and erythromycin
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Effect of loxiglumide and atropine on erythromycin-induced reduction in gallbladder volume in human subjects.
Topics: Adult; Atropine; Cholecystokinin; Erythromycin; Female; Gallbladder; Humans; Male; Pancreatic Polypeptide; Proglumide; Pulse; Ultrasonography | 1992 |